Nifedipine Tablet, Extended Release
Product Images NDC 51655-593

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 593 26)

Label for Nifedipine Extended-Release Tablets, USP 30 mg, containing 90 oral tablets. The label notes prescription-only status, storage instructions, and that tablets should be swallowed whole. The product is labeled by Northwind Health Company, LLC and includes barcodes and a QR code.*

FDA Label Image

01 (Image 01)

Chemical structure of nifedipine, showing its molecular framework with a dihydropyridine ring and attached functional groups including nitro and ester substituents.*

FDA Label Image

02 (Image 02)

A data table comparing the percentage incidence of adverse effects in patients taking Nifedipine extended-release tablets (N=707) versus placebo (N=266). It lists the adverse effects headache, fatigue, dizziness, constipation, and nausea, with higher percentages generally observed in the Nifedipine group.*

FDA Label Image

03 (Image 03)

A data table showing the percentage incidence of various adverse effects in patients taking Nifedipine extended-release tablets (N=226) compared to placebo (N=235). The table lists symptoms such as dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion with corresponding percentages for each group.*

FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.